logo

Cogent Biosciences Inc (COGT) Stock: Navigating a Year of Stock Volatility

ELVT Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Cogent Biosciences Inc’s current trading price is -48.44% away from its 52-week high, while its distance from the 52-week low is 89.65%. The stock’s price range over this period has fluctuated between $3.67 and $13.50. The company, operating within the financial sector, had a trading volume of approximately 1.21 million for the day, which was noticeably lower than the average daily share volume of 2.13 million over the last 3 months.

Cogent Biosciences Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $13.50 on 06/14/23 and the lowest value was $3.67 on 12/11/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Cogent Biosciences Inc (COGT) has experienced a quarterly rise of 50.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 723.21M and boasts a workforce of 164 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 6.29, with a change in price of -0.09. Similarly, Cogent Biosciences Inc recorded 2,208,905 in trading volume during the last 100 days, posting a change of -1.28%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for COGT stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.07.

COGT Stock Stochastic Average

Today, Cogent Biosciences Inc’s raw stochastic average for the past 50 days stands at 32.52%, indicating a decline from the raw stochastic average of the last 20 days, which was 72.67%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 77.23% and 70.54% respectively.

COGT Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 18.37% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -21.18%. Over the past 30 days, the price of COGT has fallen by 8.92%. And in the last five days, it has surged by 7.74%.